
HANOVER, Maryland, USA — The Sickle Cell Disease Association of America Inc. (SCDAA) has appointed four individuals to its Board of Directors, bringing expertise spanning healthcare investment, medical technology, public health and academic leadership to the organization.
The new appointees are Michelle Podlipsky and Crystalle Stripling, while Dr. Georges C. Benjamin and Dr. Wayne A. I. Frederick join the board as emeritus members.
Announcing the appointments, SCDAA President and CEO Regina Hartfield welcomed the new members, noting that their professional expertise, leadership and lived experiences would strengthen the association’s efforts to improve healthcare quality, expand access to treatment and enhance the lives of people affected by sickle cell disease (SCD).
New Board Members Bring Diverse Professional Experience
Michelle Podlipsky is a healthcare investor at The Carlyle Group, focusing on investments in the biopharmaceutical and life sciences sectors. Her responsibilities include evaluating healthcare companies, financial and strategic planning, and supporting business growth and transformation. She previously worked in investment banking at Morgan Stanley. Her professional interests include developments in sickle cell treatment and the challenges surrounding patient access to care. She holds bachelor’s degrees in molecular biology and business administration from the University of California, Berkeley.
Crystalle Stripling is Senior Manager of Global Commercial Education for Biosurgery at Johnson & Johnson MedTech, where she leads enterprise learning and organizational effectiveness initiatives. With more than 15 years of experience across the pharmaceutical, biotechnology and medical technology industries, Stripling brings both professional expertise and a personal commitment to sickle cell advocacy. Her experiences with the disease have informed her dedication to health equity and improving access to care for affected individuals and families. She holds degrees in chemical science, business administration and instructional design.
Two Distinguished Leaders Join as Emeritus Members
Dr. Georges C. Benjamin, Chief Executive Officer of the American Public Health Association (APHA), has led the organization since 2002. APHA is one of the world’s largest and oldest professional associations of public health workers, with a mission centered on protecting community health, promoting science-based public policy and advancing health equity. Before joining APHA, Benjamin served as Secretary of the Maryland Department of Health and Mental Hygiene, overseeing the expansion and improvement of the state’s Medicaid program.
Dr. Wayne A. I. Frederick is a surgeon, academic and former president of Howard University. Appointed interim president of the university in September 2025, he previously served as its 17th president and continues to hold the title of president emeritus and Charles R. Drew Professor of Surgery at the Howard University College of Medicine. His leadership experience includes serving as provost, chief academic officer and director of the university’s cancer center. He also continues to practice cancer surgery at Howard University Hospital. Frederick previously served as interim CEO of the American Cancer Society and its Cancer Action Network.
Strengthening the Fight Against Sickle Cell Disease
Sickle cell disease is an inherited blood disorder characterized by the production of abnormal hemoglobin, which causes red blood cells to become rigid and sickle-shaped. These cells can obstruct blood flow, resulting in complications such as anemia, jaundice, gallstones, stroke, chronic pain and organ damage. The disease can also lead to premature death.
SCDAA is a national nonprofit membership organization dedicated to advocating for people affected by sickle cell conditions and empowering community-based organizations to improve quality of life, increase public awareness and advance the search for a universal cure.
Through its network of more than 50 member organizations, SCDAA supports sickle cell research, public and professional health education, and patient and community services.
The latest board appointments reflect the association’s continued effort to strengthen its leadership capacity and advance its mission on behalf of individuals and families affected by sickle cell disease.
Source: Sickle Cell Disease Association of America Inc.
Website: https://www.sicklecelldisease.org
